A group of weight loss and diabetes treatment drugs, known as GLP-1 agonists, work by curbing appetite centers in the brain. But animal studies suggest these drugs could also potentially reduce addiction to nicotine, alcohol, and opioids. Dr. Jon LaPook explains.
California governor vetoes first-in-nation AI safety bill
September 29, 2024
